Attralus, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of AT-02 in Subjects With Systemic Amyloidosis. (NCT05951049) | Attralus, Inc. | 2023-09-21 |
| Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis (NCT05521022) | Attralus, Inc. | 2022-09-01 |
| A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis (NCT05235269) | Attralus, Inc. | 2021-11-30 |
| A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (NCT05201911) | Attralus, Inc. | 2021-11-30 |
Track Attralus, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.